Nils Thomas Von Koch

Recent News

  • CORRECTION: Thomas Von Koch Acquires Common Shares of DiaMedica Therapeutics Inc.

    Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - On July 8, 2022, Thomas Von Koch (the "Acquiror"), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the "Purchased Shares") of DiaMedica Therapeutics Inc. (the "Issuer") through the facilities of The NASDAQ Capital Market (the "Acquisition"). The Issuer's head office is located at Two Carlson Parkway, Suite 260, Minneapolis, Minnesota, 55447, U.S.A.Immediately prior to the completion of...

    2022-07-21 4:31 PM EDT
  • Thomas Von Koch Acquires Common Shares of DiaMedica Therapeutics Inc.

    Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - Thomas Von Koch (the "Acquiror"), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the "Purchased Shares") of DiaMedica Therapeutics Inc. (the "Issuer") through the facilities of The NASDAQ Capital Market (the "Acquisition"). The Issuer's head office is located at Two Carlson Parkway, Suite 260, Minneapolis, Minnesota, 55447, U.S.A.Immediately prior to the completion of the Acquisition, the Acquiror...

    2022-07-21 3:50 PM EDT